Report of ENMC workshop on the limb-girdle muscular dystrophies.
A. Clarke
DOI: https://doi.org/10.1136/jmg.29.10.753
1992-10-01
Journal of Medical Genetics
Abstract:This workshop of 37 participants took place in Soest, The Netherlands, from 28 February to 1 March 1992. It was organised by Dr Kate Bushby, with assistance from her colleagues in Newcastle upon Tyne, and from Professor Alan Emery and others at the European Neuromuscular Centre (ENMC) and European Alliance of Muscular Dystrophy Associations (EAMDA). Financial support was provided by the ENMC, the Association Frangaise Contre les Myopathies, and the Commission of the European Communities. Participants submitted clinical information on the cases they had seen of limb-girdle muscular dystrophy (LGMD) in advance of the workshop. The aims of the workshop were (1) to review the clinical experience of the participants of all forms of LGMD; (2) to establish clinical criteria to distinguish the different entities included within the compass of LGMD; and (3) to discuss the molecular genetic work in progress, and to coordinate the future work required to identify the relevant genes. The workshop was organised by topic into five sessions. The first session was an introduction to 'the problem'. After a speech of welcome from Professor Emery, Gardner-Medwin (Newcastle upon Tyne) discussed the nature of the diagnosis of LGMD, likening it to the hydra that was eventually slain by Herakles. Beckmann (Paris) then discussed the difficulties of performing linkage analyses with the clinical material available, there being few large pedigrees except in small inbred populations. The use of small families with affected sibs in linkage analysis assumes that the inheritance is recessive, rather than dominant with parental mosaicism or reduced penetrance. Suthers (Oxford) presented information about dystrophin, about the dystrophin related proteins (DRPs), often known as dystrophin isoforms, derived from the same gene at Xp21 by transcription from different promoters and by differential splicing, and about the dystrophin-like protein (DLP), the autosomal homologue encoded at a locus on chromosome 6, sometimes termed the DMDL gene. Suthers suggested that his terminology was clearer than the use of DRP to refer to the chromosome 6 homologue. Because there may be more than one DLP, he used the term 'utrophin', because so ubiquitous, to refer to the DLP encoded on chromosome 6. This is conserved across species, and is found particularly in smooth muscle and at neuromuscular junctions. Linkage analysis with the available LGMD families, including some from North Africa and Brazil, has found no evidence to implicate this locus in the disease. Finally, Bushby discussed the heterogeneity of LGMD, and presented an outline of the clinical data that had been submitted to her before the meeting of more than 90 families and sporadic cases of LGMD. She grouped families in terms of inheritance pattern, age of onset, rate of progression, and pattern of muscle involvement. The second session reviewed data from cases of recessive LGMD in specific population groups. Fardeau (Paris) presented his study of families from Reunion Island: the onset is usually at 8 to 12 years, but can be delayed to 30 years, with proximal weakness of upper and lower limbs including scapular winging. Gluteus maximus, hip adductors, latissimus dorsi, and the scapular muscles are involved first; the rate of progression is variable, even within families, but usually spares the face and the small muscles of the hand. Shortening of the Achilles tendon is found. Hypertrophy is unusual. The serum CK is substantially raised, the ECG is normal, and the EMG is myopathic. Linkage to markers from the region of the fibrillin gene on chromosome 15 has been established by Beckmann, with a lod score of 5.5 for D1SS25; the gene is localised to less than 10 Mb between 2 cM flanking markers. Jackson presented data from his study of the LGMD found in the Amish people in Indiana. The clinical features are similar to those of the Reunion group, although calf hypertrophy is recognised more commonly, and linkage has also been found to the fibrillin gene on chromosome 15, with lod score > 9 at 4 cM. Zatz and Passos-Bueno from Brazil described their pedigrees; 14 of 16 families had been excluded from linkage to utrophin on chromosome 6, six of 11 were excluded from chromosome 15, and two showed significant linkage to chromosome 15. The families linked to chromosome 15 showed intrafamilial variation in clinical course and calf hypertrophy; serum CK was increased 2 to 15 times. The other families had a preclinical 100 times increase in CK and variable calf hypertrophy (this did not help to distinguish the chromo753